Sharps Technology (STSS) will effect a 1-for-300 reverse stock split of its common stock, par value $0.0001 per share, that will become ...

X4 Pharmaceuticals (XFOR) announced that its board of directors has determined to effect a one-for-thirty reverse stock split of the company’s ...

X4 Pharmaceuticals (XFOR) said it will conduct a one-for-thirty reverse stock split of the company’s common stock.

In recent days, Boston Scientific announced a forthcoming CFO change, a Cambridge biotech undertook a 1-for-20 reverse stock ...

In addition to the impending split, shareholders will also vote on collapsing Lionsgate’s dual class stock structure, as well ...